Skip to main content
Erschienen in: Arthritis Research & Therapy 1/2020

Open Access 01.12.2020 | Correction

Correction to: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

verfasst von: Serena Colafrancesco, Maria Manara, Alessandra Bortoluzzi, Teodora Serban, Gerolamo Bianchi, Luca Cantarini, Francesco Ciccia, Lorenzo Dagna, Marcello Govoni, Carlomaurizio Montecucco, Roberta Priori, Angelo Ravelli, Paolo Sfriso, Luigi Sinigaglia, AOSD Consensus Group

Erschienen in: Arthritis Research & Therapy | Ausgabe 1/2020

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
Serena Colafrancesco and Maria Manara share the first authorship.
The original article can be found online at https://​doi.​org/​10.​1186/​s13075-019-2021-9
Correction to: Arthritis Res Ther (2019) 21:275
https://doi.org/10.1186/s13075-019-2021-9
Following publication of the original article [1], it was brought to our attention that the AOSD Consensus Group was incorrectly tagged and therefore not searchable. The publishers apologize for this error.

Acknowledgements

Experts who contributed to the project by participating in the Delphi process.
Stefano Alivernini, Institute of Rheumatology and Affine Sciences, Division of Rheumatology, Catholic University of the Sacred Heart, Rome.
Elena Baldissera, Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan.
Elena Bartoloni, Rheumatology Unit, Department of Medicine, University of Perugia, Perugia.
Alvise Berti, Department of Rheumatology, Santa Chiara Hospital, University of Trento, Trento.
Serena Bugatti, Department of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia.
Dario Camellino, Division of Rheumatology, La Colletta Hospital, Arenzano.
Daniele Cammelli, Department of Experimental and Clinical Medicine, University of Florence, Florence.
Roberto Caporali, Department of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia.
Francesco Caso, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples.
Elena Cavallaro, Department of Medical and Biological Sciences, Rheumatology Clinic, University of Udine, Udine.
Giulio Cavalli, Department of Internal Medicine, Vita-Salute San Raffaele University, Milan.
Michele Colaci, Department of Clinical and Experimental Medicine, Internal Medicine Unit, Cannizzaro Hospital, University of Catania, Catania.
Luisa Costa, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples.
Gerardo di Scala, Rheumatology Section/Immunoallergology Unit, AOU Careggi, Florence.
Giacomo Emmi, Rheumatology Section/Immunoallergology Unit, AOU Careggi, Florence.
Micol Frassi, Rheumatology and Clinical Immunology, Spedali Civili and Department of Clinical and Experimental Sciences, University of Brescia, Brescia.
Roberto Gerli, Rheumatology Unit, Department of Medicine, University of Perugia, Perugia.
Roberto Giacomelli, Department of Biotechnological and Applied Clinical Science, Division of Rheumatology, University of L’Aquila, L’Aquila.
Elisa Gremese, Institute of Rheumatology and Affine Sciences, Division of Rheumatology, Catholic University of the Sacred Heart, Rome.
Florenzo Iannone, Rheumatology Unit, Interdisciplinary Department of Medicine, University of Bari, Bari.
Giovanni Lapadula, Rheumatology Unit, Interdisciplinary Department of Medicine, University of Bari, Bari.
Lorenzo Leveghi, Department of Rheumatology, Santa Chiara Hospital, University of Trento, Trento.
Andrea Lo Monaco, Rheumatology Unit, Department of Clinical and Experimental Medicine, Sant’Anna Hospital, University of Ferrara, Ferrara.
Giuseppe Lopalco, Rheumatology Unit, Interdisciplinary Department of Medicine, University of Bari, Bari.
Raffaele Manna, Periodic Fever Research Center, Institute of Internal Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome.
Daniela Marotto, Rheumatology, Department of Medical Sciences and Public Health, Assl Olbia, Olbia.
Alessandro Mathieu, Rheumatology Unit, Department of Medical Sciences, University and AOU of Cagliari, Cagliari.
Rossella Neri, Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa.
Isabella Patisso, Periodic Fever Research Center, Institute of Internal Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome.
Matteo Piga, Rheumatology Unit, Department of Medical Sciences, University and AOU of Cagliari, Cagliari.
Leonardo Punzi, Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova.
Micol Romano, Division of Rheumatology, ASST Gaetano Pini, Milan.
Piero Ruscitti, Department of Biotechnological and Applied Clinical Science, Division of Rheumatology, University of L’Aquila, L’Aquila.
Carlo Salvarani, Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia and University of Modena e Reggio Emilia.
Raffaele Scarpa, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples.
Rossana Scrivo, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome.
Rosaria Talarico, Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa.
Elena Verrecchia, Periodic Fever Research Center, Institute of Internal Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome.
Ombretta Viapiana, Rheumatology Unit, Department of Medicine, University of Verona, Verona.
Antonio Vitale, Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease, Clinic Surgery and Neurosciences, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena.
Gianfranco Vitiello, Department of Experimental and Clinical Medicine, University of Florence, Florence.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Correction to: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts
verfasst von
Serena Colafrancesco
Maria Manara
Alessandra Bortoluzzi
Teodora Serban
Gerolamo Bianchi
Luca Cantarini
Francesco Ciccia
Lorenzo Dagna
Marcello Govoni
Carlomaurizio Montecucco
Roberta Priori
Angelo Ravelli
Paolo Sfriso
Luigi Sinigaglia
AOSD Consensus Group
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
Arthritis Research & Therapy / Ausgabe 1/2020
Elektronische ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-019-2094-5

Weitere Artikel der Ausgabe 1/2020

Arthritis Research & Therapy 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.